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Background: Patients with cirrhosis-associated hepatocellular carcinoma (HCC) rarely present with acute
pancreatitis (AP) and obstructive jaundice as the main clinical features. AP with obstructive jaundice caused by
common bile duct embolism (CBDE) is very rare.
Case presentation: A 54-year-old man with CBDE was misdiagnosed with common bile duct stones three times
over a 7-month period. Investigations during this time did not identify CBDE. Surgical exploration was performed
because of AP, obstructive jaundice, and a tumor in the left lobe of the liver. CBDE from the hepatic tumor was
diagnosed by intraoperative biopsy and frozen section examination. The patient underwent left hemihepatectomy,
cholecystectomy, and bile duct exploration.
Conclusion: Preoperative diagnosis of CBDE is difficult because of the rarity of the condition, lack of physician
awareness, and easy misdiagnosis on imaging examinations. Early and accurate diagnosis of this condition is important.
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Patients with cirrhosis-associated hepatocellular carcin-
oma (HCC) rarely present with acute pancreatitis (AP)
and obstructive jaundice as the main clinical features. AP
with obstructive jaundice caused by common bile duct
embolism (CBDE) is very rare. Preoperative diagnosis of
CBDE is difficult because of the rarity of the condition,
lack of physician awareness, and easy misdiagnosis on
imaging examinations. We report a rare case of CBDE
causing AP with obstructive jaundice, to raise awareness
of the importance of early and accurate diagnosis.
Case presentation
A 54-year-old man with type 2 diabetes mellitus and liver
cirrhosis secondary to hepatitis B virus infection was ad-
mitted to the Department of Gastroenterology at Clinical
Medical College of Yangzhou University, Jiangsu Province,
China, on 21 February 2011 because of abdominal pain.* Correspondence: bdsno1@hotmail.com
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reproduction in any medium, provided the orThe patient had a 3-day history of yellow conjunctivae
and urine. On 22 February 2011, abdominal magnetic
resonance imaging (MRI) and magnetic resonance
cholangiopancreatography (MRCP) showed a maximum
common bile duct (CBD) diameter of 13 mm with an
area of heterogeneous intensity signals in the distal por-
tion of the CBD suggestive of CBD stones (Figure 1A),
and normal intrahepatic bile ducts. There was mild ob-
struction at the duodenal ampulla (Figure 1B), liver
cirrhosis, and enlargement of the spleen. Routine
laboratory tests showed high serum levels of direct
bilirubin (DBIL) (42.5 μmol/l, normal range 1.7 to
7.8 μmol/l), total bilirubin (TBIL) (62.7 μmol/l, normal
range 5.7 to 23.5 μmol/l), aspartate aminotransferase
(AST) (91 U/l, normal range 0 to 50 U/l), alanine
aminotransferase (ALT) (206 U/l, normal range 0 to 50
U/l), and CA19-9 (821.03 U/ml, normal range <35 U/l);
normal serum levels of amylase (62 U/l, normal range
30 to 110 U/l) and alpha-fetoprotein (AFP) (6.17 ng/ml,
normal range 0 to 7 ng/ml); and a normal urinary amyl-
ase level (326 U/l, normal range 32 to 641 U/l). Endo-
scopic papillary balloon dilation (EPBD) was performed
on 23 February 2011, and the procedure reporttd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Magnetic resonance imaging findings on 22 February 2011. (A) Short inversion time inversion recovery image, showing a mildly
dilated common bile duct. Heterogeneous isointense areas (white arrow) were observed in the distal portion of the common bile duct,
suggesting common bile duct stones. (B) Magnetic resonance cholangiopancreatography, showing mild obstruction at the duodenal ampulla
(short white arrow). The common bile duct and pancreatic duct were slightly dilated (long white arrows).
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Eight days after EPBD, the plasma CA19-9 level was 469.56
U/ml, and hepatic function had improved with DBIL
10.6 μmol/l, TBIL 16.4 μmol/l, AST 36 U/l, and ALT (70
U/l). The report of a follow-up MRCP performed at an-
other hospital, at a time when the patient was asymptom-
atic, described nodular cirrhosis, enlargement of the
gallbladder, mild dilation of the intra- and extrahepatic bile
ducts, irregular areas of low signal intensity in the CBD that
were interpreted as CBD stones (Figure 2), and a 1.1 cm
diameter mass with clear borders in the lateral portion of
the left lobe of the liver that was hypointense on T1-
weighted images and slightly hyperintense on T2-
weighted images. The consulted team (surgeon, radiation
oncologist, medical oncologist, and radiologist) consid-
ered that the hepatic mass might be a benign nodule,
and should be monitored.
The patient did not return to hospital until recurrence
of pancreatitis 5 months later. He was hospitalized forFigure 2 Magnetic resonance imaging findings on 25 April
2011. Magnetic resonance cholangiopancreatography, showing
irregular hypointense areas in the common bile duct (white arrows)
with obvious dilation of the distal bile ducts. G, gallbladder; L, liver.AP and obstructive jaundice on 21 September 2011. On
admission, abdominal ultrasonography showed liver cir-
rhosis with a 27 × 38 mm area of heterogeneous echogeni-
city in the left lobe and a thickened, uneven gallbladder
containing muddy stones. The CBD was dilated (9 to
16 mm in diameter), with areas of dense, spotty echoes
referred to as muddy stones, and the left intrahepatic bile
duct was also slightly dilated. Abdominal MRI and MRCP
on the day after admission showed cholecystitis, gallblad-
der stones, a mass in the left lobe of the liver with unclear
margins that was isointense on short inversion time inver-
sion recovery sequences (Figure 3A), filling defects in the
CBD suggestive of stones (Figure 3B), dilation of the intra-
and extrahepatic bile ducts, pancreatitis, and liver cirrho-
sis. On 5 October 2011, abdominal computed tomography
(CT) showed an irregular, low-density mass measuring
27 × 38 mm in the left lobe of the liver, and a dilated CBD
with muddy stones. Contrast-enhanced CT showed in-
homogeneous enhancement of the liver mass and dilation
of the intrahepatic bile ducts. The contrast density of the
CBD stones was similar in the arterial and portal venous
phases, ranging from 15 to 22 Hounsfield units (HU).
Routine laboratory tests showed high serum levels of amyl-
ase (1,423 U/l), DBIL (136.1 μmol/l), TBIL (141.2 μmol/l),
AST (223 U/l), ALT (366 U/l), and CA19-9 (2041 U/ml); a
high urinary amylase level (6,826 U/l); and a normal serum
AFP level (6.36 ng/ml). The patient had acute epigastric
pain, fever, and jaundice. The high serum amylase level
and abdominal CT findings indicated a diagnosis of AP.
Because the pancreatitis was not severe and the pa-
tient’s condition gradually improved, emergency endo-
scopic retrograde cholangiopancreatography (ERCP) was
not performed. After the pancreatitis was stabilized,
surgical exploration of the abdomen was performed on
10 October 2011. Because of the patient’s history of liver
cirrhosis secondary to hepatitis B virus infection, there
was a high probability that the liver mass was hepatocellu-
lar carcinoma. We planned to perform cholecystectomy
Figure 3 Magnetic resonance imaging findings on 21 September 2011. (A) Short inversion time inversion recovery image, showing an
irregular, isointense mass with unclear margins (short white arrows) in the left lobe of the liver. There was fluid around the pancreas (white
arrows) indicating pancreatitis, and mild dilation of the intrahepatic bile ducts (long white arrow). (B) Short inversion time inversion recovery
image distal to the plane of image (A), showing a dilated common bile duct with an isointense filling defect (white arrow).
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the nature of the liver mass. Intraoperative exploration
showed nodular cirrhosis of the liver, an edematous gall-
bladder, a large number of muddy gallbladder stones, and
an unencapsulated tumor in the left lobe of the liver meas-
uring 45 × 35 × 25 mm. A soft grayish-white embolus
(45 × 11 × 9 mm) was extracted from the distal CBD, and
grayish-white tumor debris was observed in the left intra-
hepatic bile duct. Intraoperative biopsy and frozen section
examination showed HCC with tumor CBDE. Left hemi-
hepatectomy, cholecystectomy, and bile duct exploration
were performed. Postoperative pathological examination
of the surgical specimen confirmed moderately differenti-
ated HCC in the left lobe of the liver and the CBDE. The
surgical margins were free of tumor cells.
The serum CA19-9 level decreased to 81.20 U/ml by the
13th day after surgery, and the patient was discharged
from hospital on the 35th day after surgery. The patient
subsequently died of liver failure in another hospital on 12
February 2012.
Discussion
After reviewing the case, we consider that this patient was
misdiagnosed prior to surgical exploration. The EPBD re-
port describes extraction of muddy stones from the CBD.
The report of the MRCP performed 61 days later also de-
scribes stones in the CBD. However, it is unlikely that so
many muddy stones would have formed during this short
time. Surgical exploration eventually revealed that the
structures thought to be muddy stones were actually
CBDE from HCC. These malignant emboli may have been
misdiagnosed as muddy stones during EPBD because of
their grayish-white, friable, loose appearance.
The factors that may have contributed to the initial
misdiagnosis were: 1) absence of a visible liver mass in
the early stage of disease; 2) a normal plasma AFP level;
3) similar morphological characteristics between tumor
emboli and muddy stones, because of absence of a blood
supply (arterial phase CT was unable to differentiatebetween tumor emboli and muddy stones); 4) the rarity of
tumor emboli causing AP, compared with other causes of
AP such as metabolic abnormalities, obesity, genetic sus-
ceptibility, and the two most common causes: gallstones
and alcohol-related disease; and 5) cholecystitis associated
with muddy stones in the gallbladder, leading to the as-
sumption that AP was caused by stones in the CBD.
To our knowledge, there are very few reported cases
of AP with obstructive jaundice caused by CBDE from
cirrhosis-associated HCC. The cause of CBD obstruction
was misdiagnosed three times, mainly because of the lack
of experience of the clinicians with CBDE and the rarity of
this condition. Preoperative diagnosis is difficult, because
of the rarity of the condition, lack of physician awareness,
and easy misdiagnosis on imaging examinations. However,
the imaging tools available for diagnosis of HCC have
recently improved.
At the time of the patient’s first visit, there was no sign
of the liver mass on MRCP. We speculate that there was
probably a small HCC at that time, which may have rup-
tured into or invaded the intrahepatic bile ducts, resulting
in accumulation of tumor debris and emboli in the CBD.
Buckmaster et al. reported HCC emboli in the CBD of a
patient in whom no primary hepatic tumor was found on
preoperative CT or surgical exploration [1]. If CBDE had
been diagnosed in our patient at the first presentation, his
HCC could have been treated earlier, resulting in longer
survival. Misdiagnosis of CBDE should be avoided if
possible. Our case illustrates the importance of early
and accurate diagnosis. The common clinical features of
this condition include liver cirrhosis secondary to viral
hepatitis or other factors, high serum levels of AFP [2]
and CA19-9 (in our case, the CA19-9 level was high but
the AFP level was normal), history of cholangitis with
dilation of the intra- and extrahepatic bile ducts, rapid
development of liver dysfunction with jaundice, and a
filling defect in the common bile duct of 2 cm or longer.
If three or more of these features appear in the same
patient, CBDE should be considered.
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ating between CBDE and a CBD stone. In our case, the
contrast density of the CBDE was low in all phases of the
scan, ranging from 15 to 22 HU, whereas the contrast
density of CBD stones is usually >50 HU. When the con-
trast density of a filling defect in the CBD is ≤50 HU,
CBDE should be considered.
The prognosis of this type of HCC is generally poor,
but is better than for HCC with hepatocellular jaundice.
Jaundice does not necessarily indicate advanced disease,
and is not always a contraindication to surgery. Patients
with HCC and obstructive jaundice due to CBDE may
benefit greatly from surgery. Early and appropriate treat-
ment of such patients may achieve satisfactory palliation,
as well as occasional long-term resolution of symptoms
and survival [3-5].
Conclusion
In conclusion, we have described a very rare case of HCC
presenting as AP with obstructive jaundice. Preoperative
diagnosis is difficult, because of the rarity of the condition,
lack of physician awareness, and easy misdiagnosis on im-
aging examinations. It is important to pay attention to the
above-mentioned clinical data to obtain early and accurate
diagnosis of this condition.
Consent
Written informed consent was obtained from the patient
for the publication of this case presentation and accom-
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